Share
14 Posts.
lightbulb Created with Sketch. 11
clock Created with Sketch. 07/03/19
23:52
Share
Originally posted by sidage
↑
Dmavin - you are very astute. The presentation is a sales brochure not a true compendium of what has been done. I just checked their upcoming pain gel cap "Neuvis" and there is no application for registration on the TGA website, they have not applied for a CTN (clinical trial notification) number, there is zero published literature on Medline, there is no registered trademark and it doesn't have any product literature associated with it anywhere on the internet. To go from this ground zero status to having a ARTG listed drug would take 5-8 years and at least $10m to go through phase 1,2,3 trials. No drug company would put the drug trading name out there before they had some strong intellectual property protection in place. I'm very shocked by this brazen attempt to convince shareholders and investors that a lot of research and product development has been done. In reality, nothing has been done to bring this drug to market except design a nice brand name and a nice logo.
Expand
As I mentioned in my previous post, I'm guessing the "Neuvis" gelcap is the Auscann branded Spectrum Cannabis import. The presentation should have been clearer. I too am not convinced that they have developed a hard capsule.
